Thursday, January 27, 2022

Moderna starts trial of Omicron-specific COVID vaccine booster

Moderna says it will study its Omicron-specific booster in adults aged 18 years and older.

from Al Jazeera – Breaking News, World News and Video from Al Jazeera https://ift.tt/3Hb7nOv

Related Posts:

0 comments:

Post a Comment